Ranolazine for the treatment of pulmonary hypertension associated with heart failure with preserved ejection fraction: A pilot study

J Heart Lung Transplant. 2016 Nov;35(11):1370-1373. doi: 10.1016/j.healun.2016.07.015. Epub 2016 Jul 27.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Cardiovascular Agents / therapeutic use
  • Female
  • Heart Failure / complications
  • Heart Failure / drug therapy*
  • Heart Failure / physiopathology
  • Humans
  • Hypertension, Pulmonary / drug therapy*
  • Hypertension, Pulmonary / etiology
  • Hypertension, Pulmonary / physiopathology
  • Male
  • Pilot Projects
  • Ranolazine / therapeutic use*
  • Stroke Volume / physiology*

Substances

  • Cardiovascular Agents
  • Ranolazine